Related Experiment Video

Updated: Jul 21, 2026

Alternative Methods for the Detection of Superoxide Anion Generation in Platelets
06:35

Alternative Methods for the Detection of Superoxide Anion Generation in Platelets

Published on: March 29, 2024

C-reactive protein promotes platelet adhesion to endothelial cells: a potential pathway in atherothrombosis

Gil Yaron1, Alexander Brill, Olga Dashevsky

  • 1Department of Haematology, Hadassah Hebrew University Medical Centre, Jerusalem, Israel.

British Journal of Haematology
|July 11, 2006
PubMed

Insights

C-reactive protein (CRP) significantly increases platelet adhesion to endothelial cells, a key step in thrombosis. This finding links inflammation to cardiovascular events, highlighting CRP's prothrombotic role.

Area of Science:

  • Cardiovascular Biology
  • Inflammation and Immunology
  • Thrombosis Research

Background:

  • C-reactive protein (CRP) is a known predictor of acute cardiovascular events.
  • Emerging evidence suggests CRP has prothrombotic effects on the endothelium.

Purpose of the Study:

  • To investigate the impact of CRP on endothelial cell activation.
  • To determine CRP's role in platelet recruitment under flow conditions.

Main Methods:

  • Utilized a cone and plate(let) analyzer to assess human platelet adhesion to bovine aortic endothelial cells.
  • Employed human recombinant CRP and sera from transgenic mice expressing human CRP.
  • Investigated signaling pathways using specific inhibitors and antibodies, including anti-ICAM-1 and protein kinase C inhibitors.

Main Results:

  • CRP significantly enhanced platelet adhesion to endothelial cells in a dose- and time-dependent manner.
  • Inhibition of intercellular adhesion molecule-1 and nitric oxide donation partially blocked CRP's effect.
  • CRP-induced platelet adhesion was mediated by protein kinase C and P-selectin expression.

Conclusions:

  • CRP promotes platelet adhesion to endothelial cells, suggesting a mechanism linking inflammation and thrombosis.
  • These findings provide insight into the elevated vascular event risk associated with high CRP levels.

More Related Videos

An In Vitro Assay to Study Platelet Migration Using RGD-Functionalized Avidin-Biotin Tethers05:43

An In Vitro Assay to Study Platelet Migration Using RGD-Functionalized Avidin-Biotin Tethers

Published on: November 8, 2024

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry08:04

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry

Published on: June 10, 2025

Related Concept Videos

Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Introduction to Hemostasis01:05

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.